1. RCA-I-resistant CHO mutant cells have dysfunctional GnT I and expression of normal GnT I in these mutants enhances sialylation of recombinant erythropoietin
- Author
-
John S. Y. Goh, Zhiwei Song, Sing Fee Lim, May May Lee, Peiqing Zhang, and Kah Fai Chan
- Subjects
Glycan ,Glycosylation ,Mutant ,Bioengineering ,CHO Cells ,N-Acetylglucosaminyltransferases ,Applied Microbiology and Biotechnology ,law.invention ,chemistry.chemical_compound ,Cricetulus ,law ,Cricetinae ,Animals ,Point Mutation ,Erythropoietin ,chemistry.chemical_classification ,biology ,Chinese hamster ovary cell ,Wild type ,Molecular biology ,N-Acetylneuraminic Acid ,Recombinant Proteins ,carbohydrates (lipids) ,Complementation ,chemistry ,Recombinant DNA ,biology.protein ,Plant Lectins ,Glycoprotein ,Biotechnology - Abstract
A large number of CHO glycosylation mutants were isolated by Ricinus communis agglutinin-I (RCA-I). Complementation tests revealed that all these mutant lines possessed a dysfunctional N-acetylglucosaminyltransferase I (GnT I) gene. Sequencing analyses on the GnT I cDNAs isolated from 16 mutant lines led to the identification of nine different single base pair mutations. Some mutations result in a premature stop codon whereas others cause a single amino acid substitution in the GnT I protein. Interestingly, expression of the normal GnT I cDNA in mutant cells resulted in enhanced sialylation of N-glycans. The sialylation of recombinant erythropoietin (EPO) produced in mutant cells that were co-transfected with GnT I was enhanced compared to that of EPO produced in wild type CHO cells. The enhanced sialylation of EPO produced by JW152 cells in the presence of GnT I over CHO-K1 cells is a result of increased sialylated glycan structures with higher antennary branching. These findings represent a new strategy that may be utilized by the biotechnology industry to produce highly sialylated therapeutic glycoproteins.
- Published
- 2010
- Full Text
- View/download PDF